Chronic Obstructive Pulmonary Disease (COPD) is the only major cause of death with an increasing incidence. 2020 projections rank it fifth worldwide in terms of disease burden and it is expected to be the third leading cause of death worldwide by 2030.
The aim of this course is to provide information on COPD pathogenesis and risk factors, review COPD management options and discuss useful advice for COPD patients.
As the population ages, the importance of good bone health for patients at all ages is becoming better understood.
The aim of this course is to provide an overview of bone formation, the role of vitamin D and calcium, and other patient factors that may influence this process. Pharmacological and non-pharmacological options to maximise bone health at all ages will also be discussed.
The treatment and management of cancer incorporates the use of chemotherapy and other adjuvant and supportive agents whose function is to prevent and minimise side-effects, infections and aid in maximising patient outcomes.
The aim of this course is to provide an overview of adjuvant and supportive agents such anti-emetics, steroids and GCSF agents; their place in therapy, dosing regimens, side-effects and useful advice for patients prescribed these agents.
The management of many chronic illnesses has become increasingly complex. This in turn increases the requirement for patient monitoring, medicines reconciliation and information.
The aim of this course is to provide basic information on common blood tests, how to interpret results and calculations, and review medication that may affect or be affected by changes in blood results. It will also outline effective processes to support medicines reconciliation and information.
The number of people living with diabetes in Ireland is estimated to be almost a quarter of a million people. The Healthy Ireland survey suggests that over a million people may be at potential risk of developing type 2 diabetes. The management of diabetes and its potential complications represent a huge health and cost burden to the State.
The aim of this course is to provide an overview of the detection and diagnosis of diabetes, along with useful practice points on the management of patients with diabetes.
There is increasing awareness of mental health issues that affect children and adolescents in Ireland. Often the community pharmacist is in an ideal position to support young people and their families.
The aim of this course is to provide an overview of some of the common mental health issues that affect children such as Autism, ADHD, depression, and eating disorders. It will also include information on non-drug and licenced drug treatments of these conditions, and their role in the overall management of these conditions.
Medication safety is one of the key cornerstones for the profession of pharmacy. It is a key aspect of our daily pharmacy practice.
The aim of this course is to provide an update on medication safety issues and requirements and to facilitate best practice around medication safety in your practice.
With an ever increasing range of both prescribed and OTC medicines, pharmacists must be vigilant for the potential for Adverse Drug Reactions (ADR) and Drug Interactions.
The aim of this course is to provide information on common pathways such as the Glycoprotein P system and CYPT450 system where drug interactions are more likely to occur as well as the mechanisms of frequently reported drug interactions.
Pharmacists interact frequently with parents of babies and small children.
The aim of this course is to cover the main health concerns for parents of babies and small children. This includes information on the public health benefits of vaccination, the current vaccination schedule for babies up to 1 year and the management of common early childhood conditions.
The range of oral chemotherapy agents available, and their use in patients has risen dramatically over the last number of years. Oral chemotherapy offers many benefits to patients in terms of use of administration and access, however it also carries the same risks as traditional chemotherapy.
The aim of this express course is to provide an update on the requirements on safe supply and handling of oral chemotherapy, as well focusing on newer agents available and considering patient factors such as adherence to therapy.